Current and Emerging Formulations in Topical Antifungal Therapy: A Comparative Overview
Abstract
Fungal infections, a widespread issue, affect millions of people worldwide and can range from minor skin diseases to serious, sometimes fatal infections. Traditional topical treatments, such as creams, gels, sprays, and ointments, are popular for treating fungal infections due to their ease of use, fewer adverse effects, and safety. However, they have drawbacks like frequent application, inability to stay on the skin for extended periods, and uneven efficacy. New drug delivery technologies, such as liposomes, nanoparticles, and microemulsions, are transforming the treatment of fungal diseases by improving drug interaction with the skin, enhancing patient comfort, and reducing side effects.
Keywords: Fungal infections, Topical antifungal therapy, Nanotechnology, Therapeutic efficacy.
Keywords:
Fungal infections, Topical antifungal therapy, Nanotechnology, Therapeutic efficacyDOI
https://doi.org/10.22270/jddt.v15i5.7127References
1. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2-15. https://doi.org/10.1111/j.1439-0507.2008.01606.x PMid:18783559
2. Zhang AY, Camp WL, Elewski BE. Advances in topical and systemic antifungals. Dermatologic clinics. 2007;25(2):165-83. https://doi.org/10.1016/j.det.2007.01.002 PMid:17430754
3. Ameen M. Epidemiology of superficial fungal infections. Clinics in dermatology. 2010;28(2):197-201. https://doi.org/10.1016/j.clindermatol.2009.12.005 PMid:20347663
4. Havlickova B, Friedrich M. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses. 2008;51:16-26. https://doi.org/10.1111/j.1439-0507.2008.01615.x PMid:18783560
5. Garber G. An overview of fungal infections. Drugs. 2001;61(Suppl 1):1-12. https://doi.org/10.2165/00003495-200161001-00001 PMid:11219546
6. Tumbarello M, Tacconelli E, Pagano L, La Barbera EO, Morace G, Cauda R, et al. Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. Journal of Infection. 1997;34(1):55-60. https://doi.org/10.1016/S0163-4453(97)80010-2 PMid:9120325
7. Magdum Chandrakant S, Naikwade Nilofar S, Shah Rohit R. Preparation and evaluation of fluconazole topical microemulsion. Journal of Pharmacy Research. 2009;2(3):557-62.
8. Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay N. Comparative evaluation of efficacy and safety of topical fluconazole and clotrimazole in the treatment of tinea corporis. Journal of Pakistan Association of Dermatologists. 2012;22(4).
9. Sathyan G, Ritschel WA, Hussain AS. Transdermal delivery of tacrine: I. Identification of a suitable delivery vehicle. International journal of pharmaceutics. 1995;114(1):75-83. https://doi.org/10.1016/0378-5173(94)00214-P
10. Williams A. Transdermal and topical drug delivery: from theory to clinical practice. (No Title). 2004.
11. Guy RH. Transdermal drug delivery. Drug delivery. 2010:399-410. https://doi.org/10.1007/978-3-642-00477-3_13 PMid:20217537
12. Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Research and Technology. 2008;14(3):249-60. https://doi.org/10.1111/j.1600-0846.2008.00316.x PMid:19159369
13. Benson HA. Elastic liposomes for topical and transdermal drug delivery. Current Drug Delivery. 2009;6(3):217-26. https://doi.org/10.2174/156720109788680813 PMid:19604135
14. Güngör S, Erdal MS, Aksu B. New formulation strategies in topical antifungal therapy. Journal of Cosmetics, Dermatological Sciences and Applications. 2013;3(1):56-65. https://doi.org/10.4236/jcdsa.2013.31A009
15. Akhtar N, Verma A, Pathak K. Topical delivery of drugs for the effective treatment of fungal infections of skin. Current pharmaceutical design. 2015;21(20):2892-913. https://doi.org/10.2174/1381612821666150428150456 PMid:25925110
16. Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert opinion on drug delivery. 2010;7(11):1303-27. https://doi.org/10.1517/17425247.2010.525230 PMid:20961206
17. Hart R, Bell-Syer SE, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. Bmj. 1999;319(7202):79-82. https://doi.org/10.1136/bmj.319.7202.79 PMid:10398626 PMCid:PMC28154
18. Bhapkar P, Puttewar T, Patil R. Topic name-nail lacquers in nail diseases. IOSR Journal of Pharmacy. 2013;3(9):24-48. https://doi.org/10.9790/3013-0309-24-48
19. GÜMRÜKÇÜOĞLU N. ANTIFUNGAL COMPOUNDS. Academic Research and Reviews in Health Sciences. 2023:19.
20. Darkes MJ, Scott LJ, Goa KL. Terbinafine: a review of its use in onychomycosis in adults. American journal of clinical dermatology. 2003;4(1):39-65. https://doi.org/10.2165/00128071-200304010-00005 PMid:12477372
21. Tom LW, Elden LM, Marsh RR. Topical antifungals. PS Roland & JA Rutka, Ototoxicity, BC Decker, Hamilton, Ontario. 2004:134-9.
22. Beach DH, Goad LJ, Berman JD, Ellenberger TE, Beverley SM, Holz Jr GG. Effects of a squalene-2, 3-epoxidase inhibitor on propagation and sterol biosynthesis of Leishmania promastigotes and amastigotes. Leishmaniasis: The Current Status and New Strategies for Control: Springer; 1989. p. 885-90. https://doi.org/10.1007/978-1-4613-1575-9_111
23. Wiśniewska J, Klasik-Ciszewska S, Duda-Grychtoł K. Salicylic acid and its use in cosmetology. Aesthetic Cosmetology and Medicine. 2023;12(3):91-5. https://doi.org/10.52336/acm.2023.011
24. He Z, Huang D-C, Guo D, Deng F, Sha Q, Zhang M-Z, et al. Synthesis, fungicidal activity and molecular docking studies of tavaborole derivatives. Advanced Agrochem. 2023;2(2):185-95. https://doi.org/10.1016/j.aac.2023.05.004
25. Mucha P, Borkowski B, Erkiert-Polguj A, Budzisz E. Ciclopirox and Ciclopirox Olamine: Antifungal Agents in Dermatology with Expanding Therapeutic Potential. Applied Sciences. 2024;14(24):11859. https://doi.org/10.3390/app142411859
26. Ibrahim A, Prasad R, Ghannoum M. Antifungals. Lipids of Pathogenic Fungi (1996): CRC press; 2017. p. 235-52.
27. Nussbaumer P, Ryder NS, Stütz A. Medicinal chemistry of squalene epoxidase inhibitors. Biological Inhibitors: CRC Press; 2020. p. 1-46. https://doi.org/10.1201/9781003077336-1
28. Agarwal R, Katare O. Miconazole nitrate-loaded topical liposomes. Pharm Tech. 2002;26:48-60.
29. Firthouse PM, Halith SM, Wahab S, Sirajudeen M, Mohideen SK. Formulation and evaluation of miconazole niosomes. Int J PharmTech Res. 2011;3(2):1019-22.
30. Gupta M, Goyal AK, Paliwal SR, Paliwal R, Mishra N, Vaidya B, et al. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. Journal of liposome research. 2010;20(4):341-50. https://doi.org/10.3109/08982101003596125 PMid:20163329
31. Bachhav Y, Mondon K, Kalia Y, Gurny R, Möller M. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. Journal of controlled release. 2011;153(2):126-32. https://doi.org/10.1016/j.jconrel.2011.03.003 Mid:21397643
32. Souto E, Müller R. SLN and NLC for topical delivery of ketoconazole. Journal of microencapsulation. 2005;22(5):501-10. https://doi.org/10.1080/02652040500162436 PMid:16361193
33. Paolicelli P, Corrente F, Serricchio D, Cerreto F, Cesa S, Tita B, et al. The system SLN-Dextran hydrogel: An application for the topical delivery of ketoconazole. J Chem Pharm Res. 2011;3(4):410-21.
34. Hashem FM, Shaker DS, Ghorab MK, Nasr M, Ismail A. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. Aaps Pharmscitech. 2011;12:879-86. https://doi.org/10.1208/s12249-011-9653-7 PMid:21725708 PMCid:PMC3167257
35. Ning M, Guo Y, Pan H, Chen X, Gu Z. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug development and industrial pharmacy. 2005;31(4-5):375-83. https://doi.org/10.1081/DDC-54315 PMid:16093203
36. Ataei S, Moazeni E, Gilani K, Ghaffari A, Asgharian R, Najafabi A. In-vitro evalauation of itraconazole loaded vesicles prepared from non ionic surfactant. J Pharm Sci. 2011;1:50-2.
37. Lee E-A, Balakrishnan P, Song C-K, Choi J-H, Noh G-Y, Park C-G, et al. Microemulsion-based hydrogel formulation of itraconazole for topical delivery. Journal of pharmaceutical investigation. 2010;40(5):305-11. https://doi.org/10.4333/KPS.2010.40.5.305
38. Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian journal of pharmaceutical sciences. 2017;12(6):487-97. https://doi.org/10.1016/j.ajps.2017.07.004 PMid:32104362 PMCid:PMC7032117
39. Souto E, Wissing S, Barbosa C, Müller R. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International journal of pharmaceutics. 2004;278(1):71-7. https://doi.org/10.1016/j.ijpharm.2004.02.032 PMid:15158950
40. Radtke M, Souto EB, Müller RH. Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur. 2005;17(4):45-50.
41. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N, Patil N. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. Aaps Pharmscitech. 2009;10:289-96. https://doi.org/10.1208/s12249-009-9199-0 PMid:19294517 PMCid:PMC2663689
42. Brisaert M, Gabriëls M, Matthijs V, Plaizier-Vercammen J. Liposomes with tretinoin: a physical and chemical evaluation. Journal of pharmaceutical and biomedical analysis. 2001;26(5-6):909-17. https://doi.org/10.1016/S0731-7085(01)00502-7 PMid:11600303
43. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. International journal of pharmaceutics. 2003;258(1-2):141-51. https://doi.org/10.1016/S0378-5173(03)00183-2 PMid:12753761
44. Morrow D, McCarron P, Woolfson A, Donnelly R. Innovative strategies for enhancing topical and transdermal drug delivery. The Open Drug Delivery Journal. 2007;1(1). https://doi.org/10.2174/187412660701013606
45. Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert opinion on drug delivery. 2012;9(7):783-804. https://doi.org/10.1517/17425247.2012.686490 PMid:22559240
46. Junginger H, HOFLAND HJ, Bouwstra J. Liposomes and niosomes: interactions with human skin. Cosmetics and toiletries. 1991;106(8):45-50.
47. Maurya SD, Prajapati S, Gupta A, Saxena G, Dhakar RC, Formulation Development and Evaluation of Ethosome of Stavudine, Indian J.Pharm. Educ. Res. 2010;44(1)
48. Malhotra M, Jain N. Niosomes as drug carriers. Indian Drugs-Bombay-. 1994;31:81
49. Gupta M, Vaidya B, Mishra N, Vyas SP. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artificial Cells, Blood Substitutes, and Biotechnology. 2011;39(6):376-84. https://doi.org/10.3109/10731199.2011.611476 PMid:21951195
50. Rogerson A, Cummings J, Willmott N, Florence A. The distribution of doxorubicin in mice following administration in niosomes. Journal of pharmacy and pharmacology. 1988;40(5):337-42. https://doi.org/10.1111/j.2042-7158.1988.tb05263.x PMid:2899629
51. Bseiso EA, Nasr M, Sammour O, Abd El Gawad NA. Recent advances in topical formulation carriers of antifungal agents. Indian journal of dermatology, venereology and leprology. 2015;81:457. https://doi.org/10.4103/0378-6323.162328 PMid:26261140
52. Kakkar S, Kaur IP. Spanlastics-A novel nanovesicular carrier system for ocular delivery. International journal of pharmaceutics. 2011;413(1-2):202-10. https://doi.org/10.1016/j.ijpharm.2011.04.027 PMid:21540093
53. Kassem MA, Esmat S, Bendas ER, El‐Komy MH. Efficacy of topical griseofulvin in treatment of tinea corporis. Mycoses. 2006;49(3):232-5. https://doi.org/10.1111/j.1439-0507.2006.01221.x PMid:16681816
54. Gupta S, Ahirwar D, Sharma NK, Jhade D. Proniosomal gel as a carrier for improved transdermal delivery of griseofulvin: preparation and in-vitro characterization. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009;1(1):33-7.
55. Kaur G, Narang J. Topical nanoemulgel: A novel pathway for investigating alopecia. Journal of Nanomedicine & Nanotechnology. 2017;8(6):1-5. https://doi.org/10.4172/2157-7439.1000472
56. Neubert RH. Potentials of new nanocarriers for dermal and transdermal drug delivery. European journal of pharmaceutics and biopharmaceutics. 2011;77(1):1-2. https://doi.org/10.1016/j.ejpb.2010.11.003 PMid:21111043
57. Dhakar RC, Maurya SD, Sagar BPS, Bhagat S, Prajapati SK, Jain CP, Variables influencing the drug entrapment efficiency of microspheres: A pharmaceutical review, Der Pharmacia Lettre, 2010;2(5):102-116.
58. Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. Aaps Pharmscitech. 2009;10:917-23. https://doi.org/10.1208/s12249-009-9286-2 PMid:19609836 PMCid:PMC2802156
59. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Advanced drug delivery reviews. 2002;54:S77-S98. https://doi.org/10.1016/S0169-409X(02)00116-3 PMid:12460717
60. Malcolmson C, Satra C, Kantaria S, Sidhu A, Lawrence MJ. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. Journal of pharmaceutical sciences. 1998;87(1):109-16. https://doi.org/10.1021/js9700863 PMid:9452978
61. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. Journal of controlled release. 1997;45(2):131-40. https://doi.org/10.1016/S0168-3659(96)01559-3
62. Rahul Nair RN, Sevukarajan M, Badivaddin Mohammed BM, Jayraj Kumar JK. Formulation of Microemulsion based vaginal gel-in vitro and in vivo evaluation. 2010.
63. Pawar KR, Babu RJ. Lipid materials for topical and transdermal delivery of nanoemulsions. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2014;31(5). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2014010663 PMid:25271559
64. Thakur N, Garg G, Sharma P, Kumar N. Nanoemulsions: a review on various pharmaceutical application. Global Journal of Pharmacology. 2012;6(3):222-5.
65. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. European journal of pharmaceutics and biopharmaceutics. 2000;50(1):161-77. https://doi.org/10.1016/S0939-6411(00)00087-4 PMid:10840199
66. Yilmaz E, Borchert H-H. Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema-An in vivo study. International journal of pharmaceutics. 2006;307(2):232-8. https://doi.org/10.1016/j.ijpharm.2005.10.002 PMid:16289984
67. Srujana S, Anjamma M, Alimuddin, Singh B, Dhakar RC, Natarajan S, Hechhu R. A Comprehensive Study on the Synthesis and Characterization of TiO2 Nanoparticles Using Aloe vera Plant Extract and Their Photocatalytic Activity against MB Dye. Adsorption Science & Technology. 2022;2022 https://doi.org/10.1155/2022/7244006
68. Soriano-Ruiz JL, Calpena-Capmany AC, Cañadas-Enrich C, Bozal-de Febrer N, Suñer-Carbó J, Souto EB, et al. Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent. International journal of pharmaceutics. 2019;554:105-15. https://doi.org/10.1016/j.ijpharm.2018.11.002 PMid:30395953
69. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharmaceutical research. 2007;24:1029-46. https://doi.org/10.1007/s11095-006-9223-y PMid:17385025
70. Jones M-C, Leroux J-C. Polymeric micelles-a new generation of colloidal drug carriers. European journal of pharmaceutics and biopharmaceutics. 1999;48(2):101-11. https://doi.org/10.1016/S0939-6411(99)00039-9 PMid:10469928
71. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Advanced drug delivery reviews. 2012;64:37-48. https://doi.org/10.1016/j.addr.2012.09.013
72. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angewandte Chemie International Edition. 2009;48(30):5418-29. https://doi.org/10.1002/anie.200900441 PMid:19562807 PMCid:PMC2872506
73. Singh N, Gill V, Gill P. Nanogel based artificial chaperone technology: an overview. American Journal of Advanced Drug Delivery. 2013;1(3):271-6.
74. Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33(5):1607-17. https://doi.org/10.1016/j.biomaterials.2011.11.011 PMid:22118820 PMCid:PMC3242008
75. Glujoy M, Salerno C, Bregni C, Carlucci AM. Percutaneous drug delivery systems for improving antifungal therapy effectiveness: A review. Int J Pharm Pharm Sci. 2014;6:8-16.
76. Kumar GA, Wadood SA, Maurya SD, Ramchand D, Interpenetrating polymeric network hydrogel for stomach-specific drug delivery of clarithromycin: Preparation and evaluation, Asian Journal of Pharmaceutics-October-December 2010; 179-184. https://doi.org/10.4103/0973-8398.76738. https://doi.org/10.4103/0973-8398.76738
77. Arora R, Khan R, Ojha A, Upadhyaya K, Chopra H. Emulgel: A novel approach for hydrophobic drugs. International Journal of Pharmacy and Biological Sciences. 2017;7(3):43-60.
78. Salve K, Shinde S, Shirsath P, Shirsath P, Sonawane S. FORMULATION AND EVALUATION OF CLOTRIMAZOLE TOPICAL EMULGEL. 2024.
79. Jafari M, Abolmaali SS, Tamaddon AM, Zomorodian K, Shahriarirad B. Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine. 2021;16(10):857-77. https://doi.org/10.2217/nnm-2020-0482 PMid:33890492
80. Chauhan AS, Pandey K, Girijesh A, Dubey B, Jain P. A review on Ethosome: a novel drug delivery system for topical fungal disease. The pharma innovation journal. 2018;7(12):355-62.
81. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta pharmaceutica sinica B. 2011;1(4):208-19. https://doi.org/10.1016/j.apsb.2011.09.002
82. Kesharwani P. Dendrimer-based nanotherapeutics: Academic Press; 2021.
83. Parajapati S, Maurya S, Das M, Tilak VK, Verma KK, Dhakar RC. Potential Application of Dendrimers in Drug Delivery: A Concise Review and Update. Journal of Drug Delivery and Therapeutics. 2016;6(2):71-88 https://doi.org/10.22270/jddt.v6i2.1195
84. Gupta K, Singh S, Gupta K, Khan N, Sehgal D, Haridas V, et al. A bioorthogonal chemoenzymatic strategy for defined protein dendrimer assembly. ChemBioChem. 2012;13(17):2489-94. https://doi.org/10.1002/cbic.201200559 PMid:23042694
85. Sherje AP, Jadhav M, Dravyakar BR, Kadam D. Dendrimers: A versatile nanocarrier for drug delivery and targeting. International journal of pharmaceutics. 2018;548(1):707-20. https://doi.org/10.1016/j.ijpharm.2018.07.030 PMid:30012508
86. Sarode RJ, Mahajan HS. Dendrimers for Drug Delivery: An Overview of its Classes, Synthesis, and Applications. Journal of Drug Delivery Science and Technology. 2024:105896. https://doi.org/10.1016/j.jddst.2024.105896
87. Winnicka K, Wroblewska M, Wieczorek P, Sacha PT, Tryniszewska E. Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity. Molecules. 2012;17(4):4612-24. https://doi.org/10.3390/molecules17044612 PMid:22513487 PMCid:PMC6268403
88. Firooz A, Nafisi S, Maibach HI. Novel drug delivery strategies for improving econazole antifungal action. International journal of pharmaceutics. 2015;495(1):599-607. https://doi.org/10.1016/j.ijpharm.2015.09.015 PMid:26383840
89. Sarmah PJ, Kalita B, Sharma AK. Transfersomes based transdermal drug delivery: an overview. Int J Adv Pharm Res. 2013;4(12):2555-63.
90. Steinberg G. Cytoplasmic fungal lipases release fungicides from ultra-deformable vesicular drug carriers. PLoS One. 2012;7(5):e38181. https://doi.org/10.1371/journal.pone.0038181 PMid:22666476 PMCid:PMC3362563
91. Ghannoum M, Isham N, Herbert J, Henry W, Yurdakul S. Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations. Journal of clinical microbiology. 2011;49(5):1716-20. https://doi.org/10.1128/JCM.00083-11 PMid:21411586 PMCid:PMC3122680
92. Zaky A. Comparative study of terbinafine hydrochloride transfersome, menthosome and ethosome nanovesicle formulations via skin permeation and antifungal efficacy. Al-Azhar Journal of Pharmaceutical Sciences. 2016;54(1):18-36. https://doi.org/10.21608/ajps.2018.6631
93. Kaur IP, Rana C, Singh M, Bhushan S, Singh H, Kakkar S. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. Journal of ocular pharmacology and therapeutics. 2012;28(5):484-96. https://doi.org/10.1089/jop.2011.0176 PMid:22694593
94. ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, et al. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. Cmaj. 2017;189(24):E819-E27. https://doi.org/10.1503/cmaj.170074 PMid:28630358 PMCid:PMC5478408
95. Pugazhendhi S, Ambati B, Hunter AA. Pathogenesis and prevention of worsening axial elongation in pathological myopia. Clinical ophthalmology. 2020:853-73. https://doi.org/10.2147/OPTH.S241435 PMid:32256044 PMCid:PMC7092688
96. McAllister D, editor Microfabricated microneedles, A novel approach to transdermal drug delivery. Proceed Int'1 Symp Control Release Bioact Mater; 1998.
97. Trautman JC, Wong PS-L, Daddona PE, Kim HL, Zuck MG. Device for enhancing transdermal agent flux. Google Patents; 2001.
98. Maurya SD, Aggarwal S, Tilak VK, Dhakar RC, Singh A, Maurya G, Enhanced Transdermal Delivery of Indinavir Sulfate via Transfersomes, Pharmacie Globale (IJCP) 2010;1(06):1-7.
99. Boehm RD, Miller PR, Daniels J, Stafslien S, Narayan RJ. Inkjet printing for pharmaceutical applications. Materials Today. 2014;17(5):247-52. https://doi.org/10.1016/j.mattod.2014.04.027
100. Yang S. New medical technique punches holes in cells, could treat tumors. Retrieved on. 2007:12-3.
101. Crumay HM. Direct current: iontophoresis and galvanic surgery. Physical Modalities in Dermatologic Therapy: Radiotherapy, Electrosurgery, Phototherapy, Cryosurgery: Springer; 1978. p. 190-6. https://doi.org/10.1007/978-1-4612-6259-6_18
102. Peter M, Jui-Chen T, Gopinathan K. Skin barrier and percutaneous drug delivery. Dermatology Bolognia JL, Jorrizo JL, Rapini RP, editors London: Mosby. 2003:1969-78.
103. Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Advanced drug delivery reviews. 2001;46(1-3):281-305. https://doi.org/10.1016/S0169-409X(00)00138-1 Mid:11259844
104. Dorwal D. Nanogels as novel and versatile pharmaceuticals. Int J Pharm Pharm Sci. 2012;4(3):67-74.
105. Bencherif SA, Siegwart DJ, Srinivasan A, Horkay F, Hollinger JO, Washburn NR, et al. Nanostructured hybrid hydrogels prepared by a combination of atom transfer radical polymerization and free radical polymerization. Biomaterials. 2009;30(29):5270-8. https://doi.org/10.1016/j.biomaterials.2009.06.011 PMid:19592087 PMCid:PMC3632384
Published
Abstract Display: 724 
PDF Downloads: 604 PDF Downloads: 28 How to Cite
Issue
Section
Copyright (c) 2025 Rajveer Bhaskar, Monika Ola, Rohini Tikhe ; Vaishnavi Madwe, Arun Pawar, Shivani Khade, Sunil Shinde
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.